← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksLINEPrice Target
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

Lineage, Inc. (LINE) Price Target Analysis

Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026

Current Price
$40.52
Market reference
Price Target
$39.73
-1.9% Upside
Target Range
$32.00 — $45.00
Moderate consensus
Analyst Rating
Hold
16 analysts
Forward P/E—
Trailing P/E-94.2x
Forward PEG—
Implied Growth-7.5%
Median Target$39.00
Analyst Spread32.7%

LINE trades 1.9% above the consensus target of $39.73. Current price reflects optimism beyond analyst expectations.

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$40.52
Consensus$39.73
High$45.00
Low$32.00
Bear Case
$32
-21.0%
Consensus
$40
-1.9%
Bull Case
$45
+11.1%

Analyst Ratings Distribution

Breakdown of 16 published analyst recommendations for LINE

69% hold / mixed conviction
+3
BearishBullish
Weighted analyst sentiment score based on 16 ratings
ConsensusHold
Coverage16 Analysts
Net Score+3
Bull / Bear19% / 13%
Strong Buy00%
Buy319%
Hold1169%
Sell213%
Strong Sell00%
Strong Buy
00%
Buy
319%
Hold
1169%
Sell
213%
Strong Sell
00%
Recommendation Mix19% Buy · 69% Hold · 13% Sell
Buy (3)Hold (11)Sell (2)

LINE Price Target Analysis

Updated February 28, 2026

As of February 28, 2026, Lineage, Inc. (LINE) has a Wall Street consensus price target of $39.73, based on estimates from 16 covering analysts. With the stock currently trading at $40.52, this represents a potential downside of -1.9%. The company has a market capitalization of $9.20B.

Analyst price targets range from a low of $32.00 to a high of $45.00, representing a 33% spread in expectations. The median target of $39.00 aligns closely with the consensus average.

The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.

From a valuation perspective, LINE trades at a trailing P/E of -94.2x. Analysts expect EPS to grow -7.5% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Real Estate stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside-4.5%
Avg Forward P/E11.9x
Peers with Coverage3 / 3
CompanyMarket CapPriceTargetUpsideRatingFwd P/EAnalysts
LINELineage, Inc.
$9.2B$40.52$39.73-1.9%Hold—16
COLDAmericold Realty Trust, Inc.$3.8B$13.39$14.11+5.4%Buy—19
IIPRInnovative Industrial Properties, Inc.$1.5B$52.96$44.00-16.9%Hold11.9x11

Upside Potential Comparison

COLD
+5.4%
LINE
-1.9%
IIPR
-16.9%

See LINE's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is LINE Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare LINE vs WELL

See how LINE stacks up against sector leader Welltower Inc..

Start Comparison

Frequently Asked Questions

What is the LINE stock price target for 2026?

Wall Street's consensus price target for LINE is $39.73, -1.9% from its current price of $40.52. The below-market target from 16 analysts suggests limited near-term appreciation.

Is LINE a buy, sell, or hold?

LINE has a consensus rating of "Hold" based on 16 Wall Street analysts. The rating breakdown is mixed, with 11 Hold ratings making up the largest segment. The consensus 12-month price target of $39.73 implies -1.9% downside from current levels.

Is LINE stock overvalued or undervalued?

LINE's current price is $40.52 with a consensus target of $39.73 (-1.9% implied move). Analyst estimates suggest the stock is fairly valued at current levels.

How high can LINE stock go?

The most bullish Wall Street analyst has a price target of $45 for LINE, while the most conservative target is $32. The consensus of $39.73 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover LINE stock?

LINE is well covered by analysts, with 16 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 11 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the LINE stock forecast?

The 12-month LINE stock forecast based on 16 Wall Street analysts shows a consensus price target of $39.73, with estimates ranging from $32 (bear case) to $45 (bull case). The median consensus rating is "Hold".

Should I buy LINE stock?

Analysts are cautious on LINE, with 2 Sell ratings and a price target of $39.73 (-1.9% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do LINE price targets vary so much?

LINE analyst price targets range from $32 to $45, a 33% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $39.73 consensus represents the middle ground.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.